Drug-interactive mPEG-b-PLA-Phe(Boc) micelles enhance the tolerance and anti-tumor efficacy of docetaxel
Autor: | Rongrong Wang, Xin Teng, Feirong Gong, Zhengquan Zhu, Zhong-Kai Cui, Jiayao Duan |
---|---|
Rok vydání: | 2020 |
Předmět: |
Antitumor activity
Drug Polymeric micelles Chemistry media_common.quotation_subject anti-tumor efficacy Pharmaceutical Science RM1-950 02 engineering and technology General Medicine Pharmacology 021001 nanoscience & nanotechnology 030226 pharmacology & pharmacy Micelle 03 medical and health sciences 0302 clinical medicine Docetaxel medicine docetaxel Therapeutics. Pharmacology Clinical efficacy 0210 nano-technology polymeric micelles medicine.drug media_common |
Zdroj: | Drug Delivery, Vol 27, Iss 1, Pp 238-247 (2020) |
ISSN: | 1521-0464 1071-7544 |
DOI: | 10.1080/10717544.2020.1718245 |
Popis: | Docetaxel (DTX) is one of the most promising chemotherapeutic agents for a variety of solid tumors. However, the clinical efficacy of the marketed formulation, Taxotere®, is limited due to its poor aqueous solubility, side effects caused by the emulsifier, and low selective DTX distribution in vivo. Here a facile, well-defined, and easy-to-scale up DTX-loaded N-(tert-butoxycarbonyl)-L-phenylalanine end-capped methoxy-poly(ethylene glycol)-block-poly(D,L-lactide) (mPEG-b-PLA-Phe(Boc)) micelles (DTX-PMs) were prepared in an effort to develop a less toxic and more efficacious docetaxel formulation. The physicochemical properties, pharmacokinetics, biodistribution, and in vivo anti-tumor efficacy were evaluated in comparison to the marketed DTX formulation Taxotere®. DTX was successfully encapsulated in the hydrophobic micellar core with a high encapsulation efficiency (> 95%) and a high drug loading capacity (4.81 ± 0.08%). DTX-PMs exhibited outstanding stability in the aqueous environment due to the strong interactions between the terminal amino acid residues and docetaxel. The pharmacokinetic study in Sprague–Dawley rats revealed higher DTX concentrations in both whole blood and plasma for the group treated with DTX-PMs than that treated with Taxotere® due to the improved stability of the micellar formulation. In human non-small cell lung cancer (A549) tumor-bearing Balb/c nude mice, DTX-PMs significantly improved DTX accumulation and stalled DTX elimination in tumors than in bone marrow. Furthermore, only by half of the DTX dosage, our DTX/mPEG-b-PLA-Phe(Boc) micelles can achieve similar therapeutic effects as Taxotere®. Altogether, DTX-PMs hold great promise as a simple and effective drug delivery system for cancer chemotherapy. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |